144 related articles for article (PubMed ID: 1675455)
1. Benzodiazepine controls and the mental health system in New York State.
Perlman BB
N Y State J Med; 1991 Mar; 91(3):115. PubMed ID: 1675455
[No Abstract] [Full Text] [Related]
2. Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations.
Weintraub M; Singh S; Byrne L; Maharaj K; Guttmacher L
NIDA Res Monogr; 1993; 131():279-93. PubMed ID: 8105386
[No Abstract] [Full Text] [Related]
3. An empirical review of the impact of triplicate prescription of benzodiazepines.
Schwartz HI
Hosp Community Psychiatry; 1992 Apr; 43(4):382-5. PubMed ID: 1349557
[TBL] [Abstract][Full Text] [Related]
4. Has the New York State triplicate benzodiazepine prescription regulation influenced sedative-hypnotic overdoses?
Hoffman RS; Wipfler MG; Maddaloni MA; Weisman RS
N Y State J Med; 1991 Oct; 91(10):436-9. PubMed ID: 1684036
[TBL] [Abstract][Full Text] [Related]
5. [Benzodiazepine prescriptions at a university clinic].
Fleischhacker WW; Barnas C; Hinterhuber H
Nervenarzt; 1987 Dec; 58(12):754-8. PubMed ID: 2893302
[No Abstract] [Full Text] [Related]
6. [Benzodiazepines in pharmacy].
Hardy P
Acta Psychiatr Belg; 1985; 85(4):509-21. PubMed ID: 2865870
[TBL] [Abstract][Full Text] [Related]
7. [Anxiolytics. Principles and rules of their utilization].
Bailly D; de Chouly de Lenclave MB
Rev Prat; 1999 Sep; 49(13 Suppl):1465-71. PubMed ID: 10526498
[No Abstract] [Full Text] [Related]
8. Benzodiazepines: additional effects of the triplicate program.
N Y State J Med; 1990 May; 90(5):273-5. PubMed ID: 1971919
[No Abstract] [Full Text] [Related]
9. Unintended outcomes of medicaid drug cost-containment policies on the chronically mentally ill.
Soumerai S
J Clin Psychiatry; 2003; 64 Suppl 17():19-22. PubMed ID: 14680423
[TBL] [Abstract][Full Text] [Related]
10. Regulation of benzodiazepine prescription.
Wolfe SM; Lurie P
JAMA; 1992 Jul 22-29; 268(4):472; author reply 474. PubMed ID: 1352360
[No Abstract] [Full Text] [Related]
11. Regulation of benzodiazepine prescription.
Lurie P; Kahn JG; Wolfe SM
JAMA; 1992 Jul 22-29; 268(4):472-3; author reply 473-4. PubMed ID: 1352361
[No Abstract] [Full Text] [Related]
12. Benzodiazepine prescription regulation. Autonomy and outcome.
Glass RM
JAMA; 1991 Nov; 266(17):2431-3. PubMed ID: 1681123
[No Abstract] [Full Text] [Related]
13. Benzodiazepine use in Santiago, Chile.
Fritsch Montero R; Rojas Castillo G; Gaete Olivares J; Araya Baltra R; González Rubio I
Actas Esp Psiquiatr; 2005; 33(5):286-91. PubMed ID: 16155810
[TBL] [Abstract][Full Text] [Related]
14. Regulation of benzodiazepine prescription.
Levin AA
JAMA; 1992 Jul 22-29; 268(4):473; author reply 474. PubMed ID: 1352362
[No Abstract] [Full Text] [Related]
15. Benzodiazepines and triplicate prescriptions: New York's experience.
Uzych L
Tex Med; 1991 Sep; 87(9):6. PubMed ID: 1759252
[No Abstract] [Full Text] [Related]
16. Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations.
Weintraub M; Singh S; Byrne L; Maharaj K; Guttmacher L
JAMA; 1991 Nov; 266(17):2392-7. PubMed ID: 1681121
[TBL] [Abstract][Full Text] [Related]
17. Racial disparities in access after regulatory surveillance of benzodiazepines.
Pearson SA; Soumerai S; Mah C; Zhang F; Simoni-Wastila L; Salzman C; Cosler LE; Fanning T; Gallagher P; Ross-Degnan D
Arch Intern Med; 2006 Mar; 166(5):572-9. PubMed ID: 16534046
[TBL] [Abstract][Full Text] [Related]
18. Prescription of benzodiazepines in general practice in the county of Arhus, Denmark.
Holm M
Dan Med Bull; 1988 Oct; 35(5):495-9. PubMed ID: 2906285
[TBL] [Abstract][Full Text] [Related]
19. The short-term use of benzodiazepines.
McCurdy L
Arzneimittelforschung; 1980; 30(5a):895-7. PubMed ID: 6106492
[TBL] [Abstract][Full Text] [Related]
20. Triplicate prescription: issues and answers. Introduction.
Farnsworth PB
N Y State J Med; 1991 Nov; 91(11 Suppl):1S-4S. PubMed ID: 1771052
[No Abstract] [Full Text] [Related]
[Next] [New Search]
